(Q33654495)

28 July 2017

title

Fraudulent studies, unpublished data and their effect on the development of guidelines and evidence-based recommendations (English)

1 reference

28 July 2017

0 references

Stefan Sauerland

2

0 references

author name string

Monika Lelgemann

series ordinal

1

1 reference

28 July 2017

language of work or name

German

0 references

publication date

1 January 2010

1 reference

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen

28 July 2017

published in

1 reference

28 July 2017

volume

104

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

284-291

1 reference

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Grey literature in meta-analyses of randomized trials of health care interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Publication bias in clinical trials due to statistical significance or direction of trial results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Searching for unpublished trials in Cochrane reviews may not be worth the effort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Reporting of adverse events in systematic reviews can be improved: survey results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

What is "quality of evidence" and why is it important to clinicians?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Going from evidence to recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Dissemination and publication of research findings: an updated review of related biases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Scientific misconduct. Cleaning up the paper trail

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Randomized trials published in some Chinese journals: how many are randomized?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Do certain countries produce only positive results? A systematic review of controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Persistence of contradicted claims in the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

The COOPERATE trial: a letter of concern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Perioperative analgesia: what do we still know?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

Retractions in the research literature: misconduct or mistakes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ZEFQ.2010.03.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.ZEFQ.2010.03.035

1 reference

28 July 2017

1 reference